Evidence map›Paper›PMID 26525378›Full record

GuidelineWiener klinische Wochenschrift2015

[Treatment of haemophilia in Austria].

Ingrid Pabinger, Max Heistinger, Wolfgang Muntean, Sylvia-Elisabeth Reitter-Pfoertner, Sabine Rosenlechner, Thomas Schindl, Gerhard Schuster, Werner Streif, Katharina Thom, Christoph Male

Open access · hybridAbstract readEnglish AbstractPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Wiener klinische Wochenschrift, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Pain management in hemophilia: expert recommendations.Wiener klinische Wochenschrift · 2021
    Review
  5. Article
  6. [Pain management in rare diseases].Schmerz (Berlin, Germany) · 2020
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ingrid PabingerKlinische Abteilung für Hämatologie und Hämostaseologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich. ingrid.pabinger@meduniwien.ac.at.
Max Heistinger1. Medizinische Abteilung, LKH Klagenfurt, Klagenfurt, Österreich.
Wolfgang MunteanUniversitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Graz, Graz, Österreich.
Sylvia-Elisabeth Reitter-PfoertnerKlinische Abteilung für Hämatologie und Hämostaseologie, Universitätsklinik für Innere Medizin I, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich.
Sabine RosenlechnerKlinik Prof. Schedel, Kellberg bei Passau, Deutschland.
Thomas SchindlÖsterreichische Hämophilie Gesellschaft, Wien, Österreich.
Gerhard SchusterBlutzentrale des Roten Kreuzes, Linz, Österreich.
Werner StreifDepartment für Kinder- und Jugendheilkunde, Medizinische Universität Innsbruck, Innsbruck, Österreich.
Katharina ThomUniversitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Wien, Wien, Österreich.
Christoph MaleUniversitätsklinik für Kinder- und Jugendheilkunde, Medizinische Universität Wien, Wien, Österreich.
Medical University of Vienna · ATInnsbruck Medical University · ATKlinikum Klagenfurt · ATKlinikum Passau · DEMedical University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This guideline which is endorsed by the Austrian Society of Haemophilia, the Austrian Society of Paediatrics, and the Austrian Society of Haematology & Medical Oncology is intended to give a clear and practical guidance for diagnosing and treating haemophilia in Austria. In the treatment of haemophilia there are few controlled interventional trials, and recommendations usually have a rather low level of evidence.The main basis for this paper are the new international guidelines by the World Federation of Hemophilia, published in 2013. These were adapted according to the local situation and experience.Covered topics are diagnostics, control visits, pharmacological treatment options, prophylaxis and treatment in children and adults, possible problems arising in haemophilia carriers and special aspects like home therapy, options for venous catheters, management of various traumas, bleedings and interventions, including dental procedures, and last not least inhibitors and their treatment.

Indexed as

AustriaDrug MonitoringEvidence-Based MedicineHematologyHemophilia AHemostaticsHumansThromboembolismWounds and InjuriesHemostaticsClotting factor concentratesDesmopressinGuidelinesHaemophilia

Identifiers

PMID26525378
OpenAlexW2224102975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.